Marulanda NCJ, Gartner LE, Díaz GCJ, Aguilar MOE

Language: Spanish
References: 13
Page: 1-12
PDF size: 561.96 Kb.

ABSTRACT

Introduction: Histoplasmosis is a deep or systemic mycosis caused by a dimorphic fungus which may disseminate mainly in immunocompromised patients, such as those diagnosed with human immunodeficiency virus. Immune reconstitution syndrome is a paradoxical worsening of a known condition or a condition appearing after the start of antiretroviral therapy.
Objective: Describe a case of disseminated histoplasmosis associated to immune reconstitution syndrome in a patient with human immunodeficiency virus infection.
Case report: A case is presented of a male 32-year-old patient diagnosed with human immunodeficiency virus with a clinical status of three weeks' evolution. The current status developed after the start of antiretroviral therapy. It consisted in disseminated umbilicated papular nodules with pulmonary involvement, as well as positive Histoplasma capsulatum sl. histopathology and culture, and a positive histoplasma antigen test. A diagnosis of disseminated histoplasmosis with a cutaneous presentation was considered. It was the expression of immune reconstitution syndrome by unmasking. Treatment was started with liposomal amphotericin B, maintaining the antiretroviral therapy. Management was then continued with itraconazole for 12 months with improvement of the lesions.
Conclusions: Timely clinical, histopathological and microbiological diagnosis was performed. The patient displayed an adequate response to treatment. This mycosis is curable and even preventable when a diagnosis is made in time, treatment is started early and the retroviral therapy is maintained.

REFERENCES

1. Sepúlveda VE, Márquez R, Turissini DA, Goldman WE, Matute DR. Genome sequences reveal cryptic speciation in the human pathogen Histoplasma capsulatum. Mbio. 2017;8(6): e01339-17. doi: 10.1128/mBio.01339-17

2. Mittal J, Ponce MG, Gendlina I, Nosanchuk JD. Histoplasma Capsulatum: Mechanisms for Pathogenesis. Curr Top Microbiol Immunol. 2019;422:157-91. doi:10.1007/82_2018_114

3. Wheat LJ. Histoplasmosis: a review for clinicians from non-endemic areas. Mycoses. 2006;49(4):274-82. doi: 10.1111/j.1439-0507.2006.01253.x

4. Wheat LJ, Freifeld AG, Kleiman MB, Kleiman MB, Baddley JW, McKinsey DS, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45(7):807-25. doi: 10.1086/521259

5. Caceres DH, Knuth M, Derado G, Lindsley MD. Diagnosis of Progressive Disseminated Histoplasmosis in Advanced HIV: A Meta-Analysis of Assay Analytical Performance. J Fungi. 2019;18;(3):76-89. doi:10.3390/jof5030076

6. Deepe GS. Histoplasma capsulatum (histoplasmosis). En: Bennett JE, Dolin R, Blaser MJ, Mandell GL, Mandel Douglas, and Bennett'sPrinciples and Practice of Infectious Diseases. 8aed. Ámsterdam: Elsevier; 2015. p. 2949-62.

7. Wheat LJ, Azar MM, Bahr NC, Spec A, Relich RF, Hage C. Histoplasmosis. Infect Dis Clin North Am. 2016;30(1):207-27. doi: 10.1016/j.idc.2015.10.009

8. Delfino E, di Biagio A, Chandrapatham K, Viscoli C, Prinapori R. Disseminated histoplasmosis with mucocutaneous immune reconstitution inflammatory syndrome in an HIV-infected patient. AIDS Res Hum Retroviruses. 2015;31(3):274-5. doi: 10.1089/aid.2014.0329

9. Chang P, Rodas C. Skin lesions in histoplasmosis. Clin Dermatol. 2012;30(6):592-8. doi: 10.1016/j.clindermatol.2012.01.004

10. Nacher M, Sarazin F, El Guedj M, Vaz T, Alvarez F, Nasser V, Randrianjohany A, et al. Increased incidence of disseminated histoplasmosis following highly active antiretroviral therapy initiation. J Acquir Immune Defic Syndr. 2006;41(4):468-70. doi: 10.1097/01.qai.0000209927.49656.8d

11. Dellière S, Guery R, Candon S, Rammaert B, Aguilar C, Lanternier F, et al. Understanding Pathogenesis and Care Challenges of Immune Reconstitution Inflammatory Syndrome in Fungal Infections. J Fungi. 2018;4(4):139-161. doi: 10.3390/jof4040139

12. Manzardo C, Guardo AC, Letang E, Plana M, Gatell JM, Miro JM. Opportunistic infections and immune reconstitution inflammatory syndrome in HIV-1-infected adults in the combined antiretroviral therapy era: a comprehensive review. Expert Rev Anti Infect Ther. 2015;13(6):751-767. doi: 10.1586/14787210.2015.1029917 . Epub 2015 Apr 10

13. Kaplan JE, Benson C, Holmes KK, Brooks JT, Pau A, Masur H, et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009;58(RR-4):1-207